Surgalign Announces Appointment of David Lyle as Chief Financial Officer
March 07 2022 - 9:00AM
Surgalign Holdings, Inc. (NASDAQ: SRGA) (“Surgalign”), a global
medical technology company focused on elevating the standard of
care by driving the evolution of digital health, today announced
the appointment of David Lyle, as Chief Financial Officer,
effective immediately.
“David brings a wealth of experience in helping to guide the
growth of technologies to Surgalign at an important and exciting
inflection point of the company’s evolution,” said Terry Rich,
Surgalign’s president and chief executive officer. “David is
joining Surgalign at a critical time as we transition to the early
commercial stage of our HOLO AI technology platform, with recent
FDA clearance of our HOLO Portal™ surgical guidance system. We
believe David’s extensive financial acumen, corporate development
successes, and experience launching novel technologies will be
immediately impactful, and on behalf of our employees and the board
of directors I would like to warmly welcome him to our team.”
Mr. Lyle brings more than two decades of financial leadership
experience within the technology sector to Surgalign. He has an
established track record in successfully scaling high growth
technology companies, having served in leadership roles in both
public and private organizations. Prior to joining Surgalign, Mr.
Lyle was the CFO of Airgain, a publicly traded wireless
communications systems company. Prior to joining Airgain, Mr. Lyle
was the CFO of Sunniva, Inc., and before Sunniva, he was CFO at
Maxwell Technologies, Inc. for four years, which was acquired by
Tesla in 2019. He also served as the CFO of Entropic
Communications, Inc., which was acquired in 2015 by MaxLinear.
Prior to Entropic, he served as the CFO of RF Magic, acquired by
Entropic in 2007, Zyray Wireless, acquired by Broadcom in 2004, and
Mobilian, acquired by Intel in 2003. Mr. Lyle also has prior work
experience in the commercial banking industry. He holds a Bachelor
of Science in Business Administration from University of Southern
California, a Master of International Management from the
Thunderbird School of Global Management, and a Master of Business
Administration from Arizona State University.
“I'm thrilled to be joining Surgalign as they work to bring HOLO
technology and its tremendous potential to the market,” said Mr.
Lyle. “Machine learning and artificial intelligence have the
ability to revolutionize the way surgery is performed and
ultimately the way patients are treated. The company has made
significant progress with the early development of the platform,
and I look forward to building on that momentum in the future.”
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a global medical technology company
committed to the promise of digital health to drive transformation
across the surgical landscape. Uniquely aligned and resourced to
advance the standard of care, the company is building technologies
physicians and other health providers will look to for what is
truly possible for their patients. Surgalign is focused on
developing solutions that predictably deliver superior clinical and
economic outcomes. Surgalign markets products throughout the United
States and in more than 50 countries worldwide through an expanding
network of top independent distributors. Surgalign is headquartered
in Deerfield, IL, with commercial, innovation and design centers in
San Diego, CA, Warsaw and Poznan, Poland and Wurmlingen,
Germany.
Forward Looking Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our industry,
our management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. These statements are not guarantees of
future performance and are subject to risks and uncertainties,
including the risks described in public filings with the U.S.
Securities and Exchange Commission (SEC). Our actual results may
differ materially from the anticipated results reflected in these
forward-looking statements. Copies of the company's SEC filings may
be obtained by contacting the company or the SEC or by visiting
Surgalign's website at www.surgalign.com or the SEC's
website at www.sec.gov.
Investor and Media Contact:Mike
VallieIR@surgalign.com+1 443 213 0499
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Aug 2024 to Sep 2024
Surgalign (NASDAQ:SRGA)
Historical Stock Chart
From Sep 2023 to Sep 2024